Skip to main content
Caplight Logo









SNAP Life Sciences

SNAP Life Sciences

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://snaplifesciences.com/

Last Round

Series A

Feb 6, 2025

Total Funding Raised

$10M

Company Overview

SNAP Life Sciences is a biotechnology and pharmaceutical technology company that provides an AI-driven platform for drug asset valuation, portfolio optimization, and the exchange of intellectual property.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

biopharma deal-makingdrug asset valuationbiotech marketplaceIP exchangepharma business developmentbiotech deal flowvertical SaaSdrug licensingportfolio optimizationhealthcare analyticsAI valuation platformbiotech scoutingpharma tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SNAP Life Sciences Comparables

Compare SNAP Life Sciences with similar companies based on industry and business-model similarity.

SNAP Life Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Prudentia Sciences
88%
PhaseFolio
79%
DealForma
79%

SNAP Life Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 6, 2025

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 13, 2025

    Grew 30% QoQ, from 10 to 13 employees.

  • Aug 23, 2025

    Grew 43% QoQ from 7 to 10 employees.

SNAP Life Sciences Filings

Explore SEC and related filing metadata, where available.

SNAP Life Sciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SNAP Life Sciences's valuation, stock price, and market status.

Is SNAP Life Sciences a public or private company?

SNAP Life Sciences is a private company.

What is the current stock price of SNAP Life Sciences?

SNAP Life Sciences is a private company with no public stock price. No recent secondary market data is available.

How much is SNAP Life Sciences worth (valuation)?

Valuation information for SNAP Life Sciences is not publicly available.

Can I buy SNAP Life Sciences stock?

SNAP Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SNAP Life Sciences's last funding round?

SNAP Life Sciences's most recent funding round was Series A on February 6, 2025.

Who are the main investors in SNAP Life Sciences?

Investor information for SNAP Life Sciences is not publicly disclosed.

Will SNAP Life Sciences IPO soon?

No public IPO plans have been announced for SNAP Life Sciences.

How can I track SNAP Life Sciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SNAP Life Sciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range9
Year FoundedN/A
Last FundingFeb 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?